ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KNSA Kiniksa Pharmaceuticals Ltd

19.54
-0.45 (-2.25%)
Last Updated: 05:29:06
Delayed by 15 minutes

Kiniksa Pharmaceuticals Financial Summary

The current KNSA market cap is 1.38B. The company's latest EPS is USD 0.1994 and P/E is 98.40.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 99.14M61.88M48.35M71.47M67.05M
Operating Income 46.41M6.05M-11.2M-3.15M-33.2M
Net Income 224.09M4.46M-12.27M14.97M-13.86M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0038.54M220.18M270.26M
Operating Income -169.96M-157.36M-156.64M9.77M-25.2M
Net Income -161.87M-161.38M-157.92M183.36M14.08M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 459.95M459.67M442.86M484.33M483.06M
Total Liabilities 75.95M63.52M52.77M72.68M77.94M
Total Equity 384.01M396.15M390.1M411.66M405.13M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 254.53M349.46M232.8M459.67M526.32M
Total Liabilities 29.11M37.53M47.76M63.52M87.48M
Total Equity 225.42M311.94M185.04M396.15M438.84M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 17.38M5.81M-4.27M-8.01M8.98M
Investing 34.58M-8.08M-37.92M-2.39M-14.66M
Financing 1.33M2.52M90k248k800k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -158.37M-136.53M-126.3M5.81M13.3M
Investing 49.21M-23.44M128.64M-8.08M-29.56M
Financing 84.11M227.09M5.89M2.52M1.5M
Market Cap 1.38B
Price to Earnings Ratio 98.40
Price to Sales Ratio 5.13
Price to Cash Ratio 12.83
Price to Book Ratio 3.16
Dividend Yield -

Share Statistics

Shares Outstanding 70.62M
Average Volume (1 week) 357.81k
Average Volume (1 Month) 436.18k
52 Week Change 72.77%
52 Week High 22.10
52 Week Low 10.29
Spread (Intraday) 0.02 (0.1%)

Company Info

Company Name Kiniksa Pharmaceuticals Ltd
Address clarendon house
hamilton HM11
Website https://www.kiniksa.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock